SCHEMBL14154331

SCHEMBL14154331

C[C@@]1(F)C(O)C(CO)O[C@H]1n1cc(-c2ccccc2)c2c(N)ncnc21

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADK P55263 6/20 0.57
▸ EGFR P00533 5/20 0.54
▸ ABL1 P00519 5/20 0.54
▸ ABL2 P42684 4/20 0.54
▸ SRC P12931 10/20 0.53
▸ RIPK2 O43353 1/20 0.49
▸ ADORA2A P29274 1/20 0.47
▸ LCK P06239 2/20 0.46
▸ KDR P35968 2/20 0.46
▸ TEK Q02763 1/20 0.46
▸ JAK2 O60674 1/20 0.46
▸ NTRK1 P04629 1/20 0.46
▸ INSR P06213 1/20 0.46
▸ NPM1 P06748 1/20 0.46
▸ CSF1R P07333 1/20 0.46
▸ LYN P07948 1/20 0.46
▸ RET P07949 1/20 0.46
▸ IGF1R P08069 1/20 0.46
▸ MET P08581 1/20 0.46
▸ PDGFRB P09619 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14154296 0.90 ADK (0.57) ADKEGFRABL1ABL2SRC
SCHEMBL14470677 0.89 ADORA2A (0.60) ADKEGFRABL1ABL2SRC
SCHEMBL14470672 0.89 ADORA2A (0.60) ADKEGFRABL1ABL2SRC
SCHEMBL15241396 0.89 ADORA2A (0.60) ADKEGFRABL1ABL2SRC
SCHEMBL19276653 0.89 ADORA2A (0.60) ADKEGFRABL1ABL2SRC
SCHEMBL13092020 0.89 ADORA2A (0.60) ADKEGFRABL1ABL2SRC
SCHEMBL15225817 0.89 ADORA2A (0.60) ADKEGFRABL1ABL2SRC
SCHEMBL14154287 0.88 ADK (0.57) ADKEGFRABL1ABL2SRC
SCHEMBL14154292 0.87 ADK (0.54) ADK
SCHEMBL14154251 0.87 ADK (0.56) ADKEGFRABL1ABL2SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7405204-B2 Nucleoside compounds for treating viral infections GENELABS TECHNOLOGIES, INC. (US) 2008-07-29 — — US disclosed
Send feedback